DYSF p.Ser1711Phe
c.5132C>T · VCV3677022
ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP
Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):
PM2_Supporting PP4_Strong PM3
Curation rationale (ClinGen, verbatim)
The NM_003494.4: c.5015C>T variant in DYSF, which is also known as NM_001130987.2: c.5132C>T p.(Ser1711Phe), is a missense variant predicted to cause substitution of serine to phenylalanine at amino acid 1672, p.(Ser1672Phe). This variant has been reported in at least two patients with features consistent with LGMD (PMID: 33927379, 32528171; LOVD DYSF_001234), where it was identified in unconfirmed phase with a pathogenic variant in both (NM_003494.4: c.797G>A (p.Gly266Glu), 0.5 pts, MYO-SEQ internal data communication, PMID: 32528171; c.799_800del p.(Phe267LeufsTer5), 0.5 pts, PMID: 33927379, LOVD Individuals #00327046 and #0032760) (PM3). At least one of these individuals displayed progressive limb girdle muscle weakness and absent dysferlin on muscle biopsy (PMID: 32528171, MYO-SEQ internal data communication; PP4_Strong). This variant is absent from gnomAD v.4.1.0, meeting the criteria for PM2_Supporting. The computational predictor REVEL gives a score of 0.592, which is below the LGMD VCEP threshold of ≥0.70 (PP3 not met). In summary, this variant meets the criteria to be classified as Likely pathogenic for autosomal recessive limb-girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 03/23/2026): PM3, PP4_Strong, PM2_Supporting.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9757 | likely pathogenic ✓ concordant with ClinVar · top 7% in DYSF |
|---|---|---|
| REVEL | 0.592 | indeterminate |
| SaProt | LLR -14.28 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2, phastCons 1 |
| Regional constraint | o/e 0.97 | unconstrained · MANE · 117 kb · p 0.28 · regional, not allelic |
| Overall | ||
| CADD | 26.5 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S1672F vs ClinVar S1711F) — verify the residue.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- DYSF
- Protein
- p.Ser1711Phe
- Coding
- c.5132C>T
- MANE Select
- NM_001130987
- Type
- single nucleotide variant
- Location
- chr2:71664396 (GRCh38)
- Gene constraint
- LOEUF 0.836 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.25 · 11 PDB
Similar variants
- DYSF c.1003-3C>A Pathogenic ★★★ same condition
- DYSF c.1033+1G>A Pathogenic ★★★ same condition
- DYSF c.1033+4A>T Likely pathogenic ★★★ same condition
- DYSF c.1033+5G>A Likely pathogenic ★★★ same condition
- DYSF c.1149+1G>A Pathogenic ★★★ same condition
- DYSF c.1149+1G>C Pathogenic ★★★ same condition
- DYSF c.1149+4A>G Pathogenic ★★★ same condition
- DYSF c.1149+5G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-ser1711phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown